Drugs / Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00986232 | Apr 1999 → Apr 2000 | chickenpox, measles, mumps infectious disease, rubella | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00986232 ↗ |
| Modality | Vaccine | “Subjects 12-23 months of age received a single injection of 1 of 3 lots of an MMRV vaccine (ProQuad)” PMID 16094218 ↗ Aug 2005 |
| Route | Subcutaneous | “a single 0.5 mL subcutaneous injection of ProQuad” NCT00986232 ↗ |